New York, NY -- (SBWIRE) -- 01/29/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: JDS Uniphase Corp (NASDAQ:JDSU), ON Semiconductor Corp (NASDAQ:ONNN), PDL BioPharma Inc (NASDAQ:PDLI), Molycorp Inc (NYSE:MCP)
JDS Uniphase Corp (NASDAQ:JDSU) showed a volume of 4.26 million shares by the end of last trade whereas the average volume of the stock remained 5.56 million shares. The stock opened the session at $11.93 but then moved to $11.89. At that price, the stock showed a negative performance of -0.42%. JDS Uniphase Corporation is a provider of communications test and measurement solutions and optical products for telecommunications service providers, wireless operators, cable operators, network-equipment manufacturers (NEMs), and enterprises.
Will JDSU Get Buyers Even After The Recent Rally? Find Out Here
ON Semiconductor Corp (NASDAQ:ONNN) opened the session at $8.39 and closed the session at $8.45. The stock showed a positive performance of 0.48% in previous trading session. Traded with volume of 4.16 million shares in the prior session and the average volume of the stock remained 6.35 million shares. ON Semiconductor Corporation (ON Semiconductor) designs, manufactures and markets a portfolio of semiconductor components that address the design needs of electronic systems and products. The Company operates in three segments: Application Products Group, Standard Products Group, and SANYO Semiconductor Products Group.
For How Long ONNN will fight for Profitability? Read This Trend Analysis report
PDL BioPharma Inc (NASDAQ:PDLI) opened the session at $9.00 and closed the session at $9.02. The stock showed a positive performance of 0.89% in previous trading session. Traded with volume of 4.08 million shares in the prior session and the average volume of the stock remained 2.07 million shares. The beta of the stock remained 0.60. PDL BioPharma, Inc. (PDL) is a is a biotech company. PDL is engaged in the management of antibody humanization patents and royalty assets, which consist of its Queen et al. patents and license agreements with various biotechnology and pharmaceutical companies.
Why Should Investors Buy PDLI After The Recent Gain? Just Go Here and Find Out
Molycorp Inc (NYSE:MCP) the stock advanced 2.27% and finished the session at $4.95. Traded with volume of 4.09 million shares in the prior session and the average volume of the stock remained 8.67 million shares. The beta of the stock remained 3.28. Molycorp, Inc. provides Rare Earths and Molybdenum products to companies. The Company's rare earth products comprise of bastnasite, cerium, europium, lanthanum, neodymium, praseodymium, yttrium, and other lanthanides.
Will MCP Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)